Literature DB >> 29872221

The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma.

Heike Miess1,2, Beatrice Dankworth3, Arvin M Gouw4, Mathias Rosenfeldt5, Werner Schmitz3, Ming Jiang6, Becky Saunders6, Michael Howell6, Julian Downward2,7, Dean W Felsher4, Barrie Peck1,7, Almut Schulze8,9,10.   

Abstract

Metabolic reprogramming is a prominent feature of clear cell renal cell carcinoma (ccRCC). Here we investigated metabolic dependencies in a panel of ccRCC cell lines using nutrient depletion, functional RNAi screening and inhibitor treatment. We found that ccRCC cells are highly sensitive to the depletion of glutamine or cystine, two amino acids required for glutathione (GSH) synthesis. Moreover, silencing of enzymes of the GSH biosynthesis pathway or glutathione peroxidases, which depend on GSH for the removal of cellular hydroperoxides, selectively reduced viability of ccRCC cells but did not affect the growth of non-malignant renal epithelial cells. Inhibition of GSH synthesis triggered ferroptosis, an iron-dependent form of cell death associated with enhanced lipid peroxidation. VHL is a major tumour suppressor in ccRCC and loss of VHL leads to stabilisation of hypoxia inducible factors HIF-1α and HIF-2α. Restoration of functional VHL via exogenous expression of pVHL reverted ccRCC cells to an oxidative metabolism and rendered them insensitive to the induction of ferroptosis. VHL reconstituted cells also exhibited reduced lipid storage and higher expression of genes associated with oxidiative phosphorylation and fatty acid metabolism. Importantly, inhibition of β-oxidation or mitochondrial ATP-synthesis restored ferroptosis sensitivity in VHL reconstituted cells. We also found that inhibition of GSH synthesis blocked tumour growth in a MYC-dependent mouse model of renal cancer. Together, our data suggest that reduced fatty acid metabolism due to inhibition of β-oxidation renders renal cancer cells highly dependent on the GSH/GPX pathway to prevent lipid peroxidation and ferroptotic cell death.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29872221      PMCID: PMC6173300          DOI: 10.1038/s41388-018-0315-z

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  56 in total

1.  Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression.

Authors:  Isaac S Harris; Aislinn E Treloar; Satoshi Inoue; Masato Sasaki; Chiara Gorrini; Kim Chung Lee; Ka Yi Yung; Dirk Brenner; Christiane B Knobbe-Thomsen; Maureen A Cox; Andrew Elia; Thorsten Berger; David W Cescon; Adewunmi Adeoye; Anne Brüstle; Sam D Molyneux; Jacqueline M Mason; Wanda Y Li; Kazuo Yamamoto; Andrew Wakeham; Hal K Berman; Rama Khokha; Susan J Done; Terrance J Kavanagh; Ching-Wan Lam; Tak W Mak
Journal:  Cancer Cell       Date:  2015-01-22       Impact factor: 31.743

2.  MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism.

Authors:  Emelyn H Shroff; Livia S Eberlin; Vanessa M Dang; Arvin M Gouw; Meital Gabay; Stacey J Adam; David I Bellovin; Phuoc T Tran; William M Philbrick; Adolfo Garcia-Ocana; Stephanie C Casey; Yulin Li; Chi V Dang; Richard N Zare; Dean W Felsher
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-11       Impact factor: 11.205

Review 3.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

Review 4.  MYC on the path to cancer.

Authors:  Chi V Dang
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

5.  Ferroptosis: an iron-dependent form of nonapoptotic cell death.

Authors:  Scott J Dixon; Kathryn M Lemberg; Michael R Lamprecht; Rachid Skouta; Eleina M Zaitsev; Caroline E Gleason; Darpan N Patel; Andras J Bauer; Alexandra M Cantley; Wan Seok Yang; Barclay Morrison; Brent R Stockwell
Journal:  Cell       Date:  2012-05-25       Impact factor: 41.582

6.  Ferroptosis as a p53-mediated activity during tumour suppression.

Authors:  Le Jiang; Ning Kon; Tongyuan Li; Shang-Jui Wang; Tao Su; Hanina Hibshoosh; Richard Baer; Wei Gu
Journal:  Nature       Date:  2015-03-18       Impact factor: 49.962

7.  Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis.

Authors:  Wan Seok Yang; Katherine J Kim; Michael M Gaschler; Milesh Patel; Mikhail S Shchepinov; Brent R Stockwell
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-09       Impact factor: 11.205

8.  Determinants of human plasma glutathione peroxidase (GPx-3) expression.

Authors:  Charlene Bierl; Barbara Voetsch; Richard C Jin; Diane E Handy; Joseph Loscalzo
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

Review 9.  Mitochondrial reactive oxygen species and cancer.

Authors:  Lucas B Sullivan; Navdeep S Chandel
Journal:  Cancer Metab       Date:  2014-11-28

10.  High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas.

Authors:  Maria V Yusenko; Roland P Kuiper; Tamas Boethe; Börje Ljungberg; Ad Geurts van Kessel; Gyula Kovacs
Journal:  BMC Cancer       Date:  2009-05-18       Impact factor: 4.430

View more
  90 in total

Review 1.  Ferroptosis and kidney diseases.

Authors:  Shumei Tang; Xiangcheng Xiao
Journal:  Int Urol Nephrol       Date:  2019-11-25       Impact factor: 2.370

Review 2.  Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.

Authors:  Lisa M Butler; Ylenia Perone; Jonas Dehairs; Leslie E Lupien; Vincent de Laat; Ali Talebi; Massimo Loda; William B Kinlaw; Johannes V Swinnen
Journal:  Adv Drug Deliv Rev       Date:  2020-07-23       Impact factor: 15.470

3.  Ferroptotic agent-induced endoplasmic reticulum stress response plays a pivotal role in the autophagic process outcome.

Authors:  Young-Sun Lee; Kalishwaralal Kalimuthu; Yong Seok Park; Hima Makala; Simon C Watkins; M Haroon A Choudry; David L Bartlett; Yong Tae Kwon; Yong J Lee
Journal:  J Cell Physiol       Date:  2020-01-27       Impact factor: 6.384

4.  Gamma-Glutamyltransferase 1 Promotes Clear Cell Renal Cell Carcinoma Initiation and Progression.

Authors:  Ankita Bansal; Danielle J Sanchez; Vivek Nimgaonkar; David Sanchez; Romain Riscal; Nicolas Skuli; M Celeste Simon
Journal:  Mol Cancer Res       Date:  2019-05-31       Impact factor: 5.852

Review 5.  Population Dynamics in Cell Death: Mechanisms of Propagation.

Authors:  Michelle Riegman; Michelle S Bradbury; Michael Overholtzer
Journal:  Trends Cancer       Date:  2019-08-15

Review 6.  Progress in Understanding Ferroptosis and Challenges in Its Targeting for Therapeutic Benefit.

Authors:  Yilong Zou; Stuart L Schreiber
Journal:  Cell Chem Biol       Date:  2020-04-16       Impact factor: 8.116

7.  Ferroptosis is controlled by the coordinated transcriptional regulation of glutathione and labile iron metabolism by the transcription factor BACH1.

Authors:  Hironari Nishizawa; Mitsuyo Matsumoto; Tomohiko Shindo; Daisuke Saigusa; Hiroki Kato; Katsushi Suzuki; Masaki Sato; Yusho Ishii; Hiroaki Shimokawa; Kazuhiko Igarashi
Journal:  J Biol Chem       Date:  2019-11-18       Impact factor: 5.157

8.  RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells.

Authors:  Zili Zhang; Mei Guo; Yujia Li; Min Shen; Desong Kong; Jiangjuan Shao; Hai Ding; Shanzhong Tan; Anping Chen; Feng Zhang; Shizhong Zheng
Journal:  Autophagy       Date:  2019-11-11       Impact factor: 16.016

Review 9.  Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion.

Authors:  José Pedro Friedmann Angeli; Dmitri V Krysko; Marcus Conrad
Journal:  Nat Rev Cancer       Date:  2019-07       Impact factor: 60.716

Review 10.  The chemical basis of ferroptosis.

Authors:  Marcus Conrad; Derek A Pratt
Journal:  Nat Chem Biol       Date:  2019-11-18       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.